A validation study of crescents in predicting ESRD in patients with IgA nephropathy-Reference-Cited by-同舟云学术

A validation study of crescents in predicting ESRD in patients with IgA nephropathy

Published:2018-05-03 Issue:1 Volume:16 Page:
ISSN:1479-5876
Container-title:Journal of Translational Medicine
language:en
Short-container-title:J Transl Med

Author:

Zhang Xiaoyan,Shi Sufang,Ouyang Yan,Yang Meng,Shi Manman,Pan Xiaoxia,Lv Jicheng,Wang Zhaohui,Ren Hong,Shen Pingyan,Wang Weiming,Zhang Hong,Xie Jingyuan,Chen Nan

Funder

Shanghai Jiao Tong University School of Medicine Multi-Center Clinical Research Project

National Key Research and Development Program of China

National Key Technology R&D Program

National Natural Science Foundation of China

Science and Technology Innovation Action Plan of Shanghai Science and Technology Committee

Shanghai Municipal Education Commission, Gaofeng Clinical Medicine Grant

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12967-018-1488-5.pdf

Reference28 articles.

1. Xie J, Chen N. Primary glomerulonephritis in mainland China: an overview. Contrib Nephrol. 2013;181:1–11.

2. Levy M, Berger J. Worldwide perspective of IgA nephropathy. Am J Kidney Dis. 1988;12:340–7.

3. Xie J, Kiryluk K, Wang W, Wang Z, Guo S, Shen P, Ren H, Pan X, Chen X, Zhang W, et al. Predicting progression of IgA nephropathy: new clinical progression risk score. PLoS ONE. 2012;7:e38904.

4. Yang M, Xie J, Ouyang Y, Zhang X, Shi M, Li X, Wang Z, Shen P, Ren H, Zhang W, et al. ABO blood type is associated with renal outcomes in patients with IgA nephropathy. Oncotarget. 2017;8:73603–12.

5. Ouyang Y, Xie J, Yang M, Zhang X, Ren H, Wang W, Chen N. Underweight is an independent risk factor for renal function deterioration in patients with IgA nephropathy. PLoS ONE. 2016;11:e0162044.

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunosuppressant Agents as Add-On Therapy Failed to Improve the Outcome of Immunoglobulin A Nephropathy with Crescent Score C1;Nephron;2024-05-09

2. Clinical and pathological findings of IgA nephropathy following SARS-CoV-2 infection;Clinical and Experimental Medicine;2024-02-24

3. Nomogram for the prediction of crescent formation in IgA nephropathy patients: a retrospective study;BMC Nephrology;2023-09-04

4. Crescents proportions above 10% are associated with unfavorable kidney outcomes in IgA nephropathy patients with partial crescent formation;Renal Failure;2023-06-25

5. The predictive value and response to immunosuppressive therapy of IgA nephropathy patients with crescents in a large retrospective Chinese cohort;Clinical Kidney Journal;2023-06-07